Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib

详细信息    查看全文

• 作者：Elena Conca ; Claudia Mir ; a ; Valentina Dal Col ; Elena Fumagalli ; Giuseppe Pelosi ; Mara Mazzoni ; Maurizio Fermeglia ; Erik Laurini ; Marco A. Pierotti ; Silvana Pilotti ; Angela Greco ; Sabrina Pricl ; Elena Tamborini
• 关键词：GIST ; Imatinib ; KIT mutations ; Molecular modeling ; Free energy of binding ; Functional analysis
• 刊名：Molecular Oncology
• 出版年：2013
• 出版时间：August, 2013
• 年：2013
• 卷：7
• 期：4
• 页码：756-762
• 全文大小：1259 K

文摘

Gastrointestinal stromal tumors carry in about 85 % of the cases activating mutations in KIT gene. Generally only one KIT mutation is found in primary tumors and the majority of mutations affecting KIT exon 11 is sensitive to Imatinib.

We report upon a GIST case harboring a double-mutant KIT gene at exon 11, which expresses a receptor bearing the known activating W557G mutation and a newly discovered missense Y578C alteration. The relative affinities for ATP and Imatinib of each single (W557G, Y578C) and double (W557G/Y578C) mutant KITs were predicted by in silico studies (computer-based molecular simulations), and compared with those obtained for known Imatinib sensitive and resistant KIT mutants. In parallel, biochemical analysis of the single and double KIT mutants expressed in mammalian cells was performed. Both the in-silico/in-vitro investigations showed constitutive activation and sensitivity to Imatinib of the yet mentioned Y578C mutation as well as of the double mutant, providing evidence that the concomitant presence of the W557G and Y578C mutations does not affect Imatinib response compare to the single mutations, in line with what observed in Imatinib treated patient.